Gene · 2549
Papers2,374
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,374
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A macropinocytosis-related gene signature predicts the prognosis and immune microenvironment in hepatocellular carcinoma. | Front Oncol | 2023 | 37064147 | PubTator, text mining | PubMed |
| ASAP2 interrupts c-MET-CIN85 interaction to sustain HGF/c-MET-induced malignant potentials in hepatocellular carcinoma. | Exp Hematol Oncol | 2023 | 37061723 | PubTator, text mining | PubMed |
| High expression of the RET receptor tyrosine kinase and its ligand GDNF identifies a high-risk subset of estrogen receptor positive breast cancer. | Breast Cancer Res Treat | 2023 | 37061618 | PubTator, text mining | PubMed |
| Emerging evidence that the mammalian sperm epigenome serves as a template for embryo development. | Nat Commun | 2023 | 37059740 | PubTator, text mining | PubMed |
| YME1L overexpression exerts pro-tumorigenic activity in glioma by promoting Gαi1 expression and Akt activation. | Protein Cell | 2023 | 37051674 | PubTator, text mining | PubMed |
| Gαi1/3 mediation of Akt-mTOR activation is important for RSPO3-induced angiogenesis. | Protein Cell | 2023 | 37051672 | PubTator, text mining | PubMed |
| Chitosan Oligosaccharide Promotes Junction Barrier through Modulation of PI3K/AKT and ERK Signaling Intricate Interplay in T84 Cells. | Polymers (Basel) | 2023 | 37050295 | PubTator, text mining | PubMed |
| The Effect of Metformin and Carbohydrate-Controlled Diet on DNA Methylation and Gene Expression in the Endometrium of Women with Polycystic Ovary Syndrome. | Int J Mol Sci | 2023 | 37047828 | PubTator, text mining | PubMed |
| Exposure to Insecticides Modifies Gene Expression and DNA Methylation in Hematopoietic Tissues In Vitro. | Int J Mol Sci | 2023 | 37047231 | PubTator, text mining | PubMed |
| The Matrix Reloaded-The Role of the Extracellular Matrix in Cancer. | Cancers (Basel) | 2023 | 37046716 | PubTator, text mining | PubMed |
| The Role of cMET in Gastric Cancer-A Review of the Literature. | Cancers (Basel) | 2023 | 37046637 | PubTator, text mining | PubMed |
| MicroRNA-142-3p promotes renal cell carcinoma progression by targeting RhoBTB3 to regulate HIF-1 signaling and GGT/GSH pathways. | Sci Rep | 2023 | 37045834 | PubTator, text mining | PubMed |
| Targeting thiol isomerase activity with zafirlukast to treat ovarian cancer from the bench to clinic. | FASEB J | 2023 | 37043381 | PubTator, text mining | PubMed |
| A transcriptomics approach to expand therapeutic options and optimize clinical trials in oncology. | Ther Adv Med Oncol | 2023 | 37025260 | PubTator, text mining | PubMed |
| Outcomes of a radiation sparing approach in medulloblastoma by subgroup in young children: an institutional review. | Childs Nerv Syst | 2023 | 37022464 | PubTator, text mining | PubMed |
| A sellar presentation of a WNT-activated embryonal tumor: further evidence of an ectopic medulloblastoma. | Acta Neuropathol Commun | 2023 | 37013660 | PubTator, text mining | PubMed |
| The Preclinical Pharmacology of Tepotinib-A Highly Selective MET Inhibitor with Activity in Tumors Harboring MET Alterations. | Mol Cancer Ther | 2023 | 36999986 | PubTator, text mining | PubMed |
| CHEK2 Alterations in Pediatric Malignancy: A Single-Institution Experience. | Cancers (Basel) | 2023 | 36980535 | PubTator, text mining | PubMed |
| Pediatric brain tumors: A neuropathologist's approach to the integrated diagnosis. | Front Pediatr | 2023 | 36969278 | PubTator, text mining | PubMed |
| Unleashing the potential of combining FGFR inhibitor and immune checkpoint blockade for FGF/FGFR signaling in tumor microenvironment. | Mol Cancer | 2023 | 36966334 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2549/papers?page=11